Observations on the use of Bruton ’s tyrosine kinase inhibitors in SAR-CoV-2 and cancer

Bruton ’s tyrosine kinase (BTK) inhibitors, drugs utilized in cancer, are being repurposed for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (COVID-19). Recently, BTK inhibitors acalabrutinib and...

Source: Journal of Hematology and Oncology - January 13, 2021 Category: Hematology Authors: Brooke Benner and William E. Carson Tags: Letter to the Editor Source Type: research